Urethral discharge

R18_URETHRAL_DISCH

urethral disease: A disease involving the urethra. [database_cross_reference: MONDO:DesignPattern]

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R36 Cause of death: ICD-10 — R36 2 out of 7 registries used, show all original rules.	57
4. Check minimum number of events None	57
5. Include endpoints None	57
6. Filter based on genotype QC (FinnGen only)	52

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R3
Name in latin: Fluor urethralis

NAME	R18_URETHRAL_DISCH
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_URINARY_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R36
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R36
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Urethral discharge based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	52	17	35
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	51.25	44.85	54.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
54: Matched controls
540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R36

ICD-10 Finland

Urethral discharge

+∞

77.3

UKC02

NOMESCO Finland

Cystoscopy

26.6

33.9

R31

ICD-10 Finland

Unspecified haematuria

50.2

10.5

XKD00

NOMESCO Finland

Uroflowmetry

7.2

10.0

N06AX16

ATC

venlafaxine; oral

6.3

8.4

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

46.0

7.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

6.8

6.6

T36

ICD-10 Finland

Poisoning by systemic antibiotics

30.7

6.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3049717) Cytology report of Urine Cyto stain

17.11

6.69

1.9

3.7

—

(3026008) Bacteria identified in Urine by Culture

3.97

5.57

3.8

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4.05

4.87

3.8

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4.04

4.66

3.5

2.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

146

3.37

4.61

5.8

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

122

3.18

4.15

5.7

2.1

0.15

0.29

e6/l

0.43

(3015736) pH of Urine

171

3.14

4.06

5.5

2.8

5.97

6.04

0.16

(3018095) Leukocytes [#/volume] in Urine

166

3.04

3.87

7.6

2.8

9.70

8.05

e6/l

0.14

107

(3021601) Nitrite [Presence] in Urine by Test strip

222

3.12

3.72

6.3

3.1

0.00

estimate

-0.00

(3026782) Osmolality of Urine

3.17

3.65

3.6

2.4

555.32

550.22

mosm/kgh2o

0.04

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3.37

3.62

5.3

1.9

0.40

2.61

e6/l

—

(3035350) Ketones [Presence] in Urine by Test strip

225

3.05

3.57

6.3

3.1

0.00

estimate

-0.00

(3000850) Epithelial cells [#/volume] in Urine

2.98

3.47

4.0

2.2

2.41

2.63

e6/l

0.10

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3.19

3.46

5.1

1.9

0.62

0.59

e6/l

—

(3009261) Glucose [Presence] in Urine by Test strip

231

2.91

3.30

6.3

3.1

0.00

estimate

-0.00

(3003694) ABO and Rh group [Type] in Blood

136

2.76

3.26

1.7

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4.92

3.16

4.6

2.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

8.25

3.14

3.2

1.3

72.17

66.98

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3.94

2.62

3.7

2.8

0.79

1.66

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3.94

2.62

7.4

1.6

24.67

24.38

mmol/l

—

(3024928) Oxygen saturation in Venous blood

5.98

2.62

3.3

2.2

72.80

66.23

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2.68

2.59

1.5

1.6

—

(3018418) pH of Serum or Plasma

117

2.49

2.55

5.7

3.6

7.40

0.05

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

168

2.38

2.48

5.9

3.1

0.00

estimate

—

(42870588) Differential panel, method unspecified - Blood

143

2.39

2.46

6.2

5.8

—

(3000991) Gas panel - Venous blood

3.27

2.36

13.6

7.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

129

2.36

2.35

6.0

2.7

0.00

estimate

—

(40768443) Skin Pathology biopsy report

5.04

2.34

2.3

1.2

—

(3002256) Pathology report gross observation

2.86

2.29

1.6

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

5.99

2.26

1.2

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

124

2.31

2.19

6.5

3.2

0.00

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

109

2.33

2.15

2.6

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

251

2.30

2.14

7.6

10.6

3.66

4.28

e9/l

1.08

228

(3019198) Lymphocytes [#/volume] in Blood

222

2.25

2.14

6.4

6.7

1.99

1.80

e9/l

1.03

205

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3.86

2.13

3.9

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3.43

2.11

4.0

2.7

0.55

0.63

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.56

2.10

2.7

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.68

2.05

1.9

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3.67

2.04

5.9

9.2

26.23

23.87

mmol/l

—

(3013115) Eosinophils [#/volume] in Blood

227

2.17

1.97

6.4

6.7

0.20

0.19

e9/l

0.07

207

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3.50

1.95

1.3

2.0

—

(40758558) Short blood count panel - Blood

113

2.22

1.95

9.9

6.2

—

(3032080) INR in Blood by Coagulation assay

200

2.13

1.93

7.5

11.1

1.08

1.20

inr

1.14

162

(3001604) Monocytes [#/volume] in Blood

219

2.13

1.92

6.5

6.8

0.54

0.60

e9/l

1.11

199

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.57

1.90

9.8

5.7

101.83

104.13

mmol/l

0.44

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

239

2.14

1.89

8.3

6.6

10.89

11.15

umol/l

0.07

228

(3006315) Basophils [#/volume] in Blood

220

2.12

1.88

6.5

6.8

0.04

e9/l

0.45

201

(3027008) Opiates [Presence] in Urine

3.34

1.87

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

3.34

1.87

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

3.34

1.87

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4.47

1.86

1.2

1.1

30.18

28.83

iu/l

—

(3012544) pH of Venous blood

2.62

1.85

7.7

2.5

7.36

7.40

—

(3002032) Base excess in Venous blood by calculation

2.62

1.85

7.7

2.5

1.53

2.31

mmol/l

0.43

(3000494) Fungus identified in Specimen by Culture

2.47

1.77

1.0

1.6

—

(3023368) Bacteria identified in Blood by Culture

110

2.12

1.72

9.2

4.6

—

(40761536) Microorganisms panel - Urine sediment

2.75

1.67

7.1

3.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

277

2.07

1.64

7.1

4.3

6.61

6.60

mmol/l

0.02

253

(3033658) Prothrombin time (PT) actual/Normal

112

2.07

1.63

9.7

3.5

90.68

87.88

0.27

112

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

3.24

1.63

1.7

1.6

—

250.44

—

(36660697) Celiac disease serology panel - Serum

2.67

1.61

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

147

1.98

1.58

2.7

2.8

0.64

0.75

ug/l

0.41

(3034770) Mitochondria Ab [Titer] in Serum

3.56

1.56

1.2

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.56

1.52

3.2

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

204

1.91

1.49

9.1

5.5

1.19

1.20

mmol/l

0.49

172

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.43

1.45

6.6

3.1

—

(3016879) Cocaine [Presence] in Urine

2.80

1.41

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

3.13

1.39

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

163

1.85

1.34

6.7

2.9

33.29

33.33

u/l

0.00

149

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

183

1.81

1.28

3.8

4.4

26.09

24.05

—

(3019150) Specific gravity of Urine by Refractometry

1.92

1.20

6.3

2.8

1.02

kg/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.65

1.18

1.4

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2.13

1.15

1.9

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

100

1.85

1.13

2.0

1.8

1.17

1.43

mg/l

—

(3009508) Creatinine [Moles/volume] in Urine

161

1.75

1.13

3.5

2.9

8.42

8.95

mmol/l

0.13

147

(3000492) Spirometry study

2.01

1.08

1.2

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.05

1.05

4.2

2.5

5.70

6.31

umol/l

—

(3044640) Blood type and Crossmatch panel - Blood

137

1.73

1.04

3.2

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

212

1.67

1.01

3.4

2.5

—

estimate

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

345

1.78

0.98

12.1

8.0

77.34

78.42

u/l

0.07

331

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

113

1.74

0.97

1.3

0.68

1.03

u/ml

—

(3042936) Bacteria identified in Isolate by Culture

1.87

0.90

2.2

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

309

1.63

0.84

3.7

3.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.29

0.78

2.0

1.8

—

(3027944) Amphetamines [Presence] in Urine

2.29

0.78

1.4

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.10

0.75

1.0

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.69

0.73

1.6

2.6

1.43

1.48

0.09

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.01

0.72

1.0

—

(3012516) Albumin [Mass/volume] in Urine

149

1.54

0.72

3.9

3.1

66.60

41.12

mg/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.72

0.70

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

150

1.53

0.70

4.6

4.0

12.94

6.23

mg/mmol

—

100

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

198

1.49

0.67

2.4

1.9

104.87

93.60

pmol/l

0.67

100

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

191

1.46

0.62

5.2

3.5

17.45

59.74

ng/l

1.32

128

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.86

0.61

3.2

3.1

1.20

1.23

mmol/l

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.59

0.0

2.4

—

4.38

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.60

0.58

1.8

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.55

0.55

2.7

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

469

0.67

0.43

5.5

4.0

1.44

1.31

mmol/l

0.41

443

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.8

—

1.23

—

(4034850) Laboratory test

0.00

0.42

0.0

3.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.8

—

0.24

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.1

—

(40768797) Stomach Pathology biopsy report

1.41

0.41

1.0

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.32

0.29

3.0

2.1

—

(3037522) Nuclear Ab [Titer] in Serum

1.25

0.28

1.1

1.6

—

458.46

—

(40760892) CBC W Ordered Manual Differential panel - Blood

108

1.27

0.23

2.2

6.4

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

0.00

0.21

0.0

2.0

—

120.60

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.21

0.0

3.3

—

1.45

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

138

1.23

0.20

3.4

3.6

1153.45

760.61

ng/l

0.33

113

(3022145) Colonoscopy Study observation

1.22

0.20

1.7

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

3.2

—

11.09

—

(40768804) Tissue Pathology biopsy report

164

1.15

0.11

2.2

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.12

0.10

3.2

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.05

0.09

4.0

1.7

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1.08

0.09

2.2

2.1

3.08

3.45

mmol/l

—

(1761868) Lipid panel - Serum or Plasma

226

1.11

0.08

4.1

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.10

0.08

2.4

3.44

3.34

ratio

—

(3013512) EKG study

169

1.10

0.06

5.0

3.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

105

0.94

0.00

3.6

2.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

3.3

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

15.00

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3011412) CD3 cells [#/volume] in Blood

0.00

-0.00

0.0

2.9

—

902.43

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.4

—

442.80

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

-0.00

0.0

2.4

—

4.40

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

3.05

—

(3010503) CD19 cells [#/volume] in Blood

0.00

-0.00

0.0

2.0

—

138.40

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

0.00

-0.00

0.0

3.0

—

109.60

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.82

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

483

1.16

-0.00

6.1

4.8

1.28

1.41

mmol/l

1.99

457

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.2

—

18.00

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

31.20

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

-0.00

0.0

1.2

—

(4062490) Immunoglobulin typing, IgG

0.00

-0.00

0.0

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.02

-0.00

6.6

6.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

1.4

—

17.20

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

1.8

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

7.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

0.00

-0.00

0.0

2.8

—

7.80

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(1175426) CD3 cells/Lymphocytes in Blood

0.00

-0.00

0.0

3.2

—

71.40

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

1.67

—

(3025577) Chromium [Mass/volume] in Blood

0.00

-0.00

0.0

2.4

—

2.66

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3023419) Bacteria identified in Sputum by Culture

0.00

-0.00

0.0

2.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

5.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_URETHRAL_DISCH – Urethral discharge

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Urethral discharge

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Urethral discharge (R18_URETHRAL_DISCH)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints